Clinical Research

Taking a drug candidate from preclinical studies through a complete clinical drug development program requires an enormous commitment of resources and bears a number of potential risks.  However, the rewards for succeeding cannot be equaled.  Selecting an experienced, knowledgeable Contract Research Organization (CRO) could make the difference between successfully bringing your product to market, quickly and safely and becoming stalled in the development process.

SGS’ Life Science Services has 30 years of experience as a global CRO providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing. With over 1,300 employees and 2,000 trials performed, SGS serves the pharmaceutical, biotechnology and medical device industries.

SGS’ state of the art facilities include: three Phase I units with a total of 162 beds, four bioanalytical labs, and Phase II-IV clinical trial management offices across Europe, North America & Asia.  With innovative study designs, optimal facilities and strong regulatory intelligence, SGS can significantly improve client’s drug development timelines and decision-making processes.